District Court, D. Massachusetts February 14, 1995, Civ. A. 94-11818-WGY (Amgen, Inc. v. Genetics Institute, Inc.)

Also known as

United States · · · 14-02-1995

MEMORANDUM AND ORDER

YOUNG, District Judge.

This action is the latest front in a scientific and legal war, now into its second decade, over the production and purification of erythropoietin (“EPO”).

1

EPO is a human protein that stimulates the production of red blood cells and is used primarily for the clinical treatment of anemia, particularly anemia caused by renal disease.

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.